LONDON, Nov 15 (Reuters) - Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around $20 per test to $5, to help tackle low testing ...
Danaher Corp. posted third-quarter earnings and sales ahead of Wall Street expectations and backed its projection for 2024 sales growth, bolstered by growing demand for its Cepheid medical-testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback